BEIJING – A senior Chinese trade official welcomed continued investment from Danish pharmaceutical giant Novo Nordisk during a Friday meeting in Beijing, according to government statements.
Vice Commerce Minister Ling Ji met with an executive vice president from the diabetes and obesity medication manufacturer, expressing the government’s desire for the company to maintain its business operations in the country.
“Continue to cultivate the Chinese market and contribute to building a healthy China,” Ling Ji told the Novo Nordisk representative during their discussion, the commerce ministry reported.
The meeting reflects ongoing diplomatic and commercial ties between China and international pharmaceutical companies as the country seeks to strengthen its healthcare infrastructure.
